ClinicalTrials.gov record
Terminated Phase 2Phase 3 Interventional Results available

Study to Investigate the Safety and Efficacy of Lithium in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

ClinicalTrials.gov ID: NCT00818389

Public ClinicalTrials.gov record NCT00818389. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 4, 2026, 11:41 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Double-Blind, Placebo-Controlled, Study to Investigate the Safety and Efficacy of Lithium in Combination With Riluzole in Volunteers With Amyotrophic Lateral Sclerosis (ALS)

Study identification

NCT ID
NCT00818389
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2, Phase 3
Lead sponsor
Massachusetts General Hospital
Other
Enrollment
84 participants

Conditions and interventions

Interventions

  • Lithium Carbonate Drug
  • Riluzole Drug
  • placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2008
Primary completion
Sep 30, 2009
Completion
Sep 30, 2009
Last update posted
Apr 18, 2011

2009

United States locations

U.S. sites
22
U.S. states
17
U.S. cities
22
Facility City State ZIP Site status
Phoenix Neurological Assoc., 1331 N. 7th Street, Suite 350 Phoenix Arizona 85006
Cedars-Sinai ALS Center, Neurology Specialty Clinic, 8730 Alden Drive, Thalians, E 245 Los Angeles California 90048
UCSF ALS Center, University of California San Francisco, Neurology, Box 0114, UCSF San Francisco California 94143
Mayo Clinic-Jacksonville, Neurology Department, 4500 San Pablo Road Jacksonville Florida 32224
University of Miami, Miller School of Medicine, 1150 NW 14th Street, Suite 609 (SCs are suite 701) Miami Florida 33136
Indiana University, Department of Neurology, 1050 Wishard Blvd, RG 6 Indianapolis Indiana 46202
University of Kentucky Medical Center, BAMC, Department of Neurology, Room A307, 1101 Veteran's Drive Lexington Kentucky 40502'
Johns Hopkins University, Department of Neurology, 600 N. Wolfe St, Meyer 6-181 Baltimore Maryland 21287
Massachusetts General Hospital, 149 13th St, Room 2266 Charlestown Massachusetts 02129
Wayne State University, Department of Neurology, 4201 St. Antoine, 8C UHC Detroit Michigan 48201
Hennepin County Medical Center, Dept of Neurology, 701 Part Ave S, P5-200 Minneapolis Minnesota 55415
Washington University, 660 S. Euclid Ave., Box 8111 Neurology St Louis Missouri 63110
Columbia Univ Med Ctr, Eleanor and Lou Gehrig ALS/MDA Center, 710 West 168th St, 9th Floor New York New York 10032
SUNY Upstate Medical University, 750 E Adams St, 6610UH Syracuse New York 13210
Duke University Medical Center, Box 3333 Durham North Carolina 27707
Wake Forest University, ALS Center, Paul Sticht Center, Ground Floor, Medical Center Blvd Winston-Salem North Carolina 27157-1078
Ohio State University, Neuromuscular Division, 1654 Uphan Drive, 417 Means Hall Columbus Ohio 43210
Penn State Hershey Medical Center, Department of Neurology, H037, Pennsylvania State Hershey Medical Center Hershey Pennsylvania 17033
Drexel University College of Medicine, 245 North 15th Street Philadelphia Pennsylvania 19103
Texas Neurology, PA, 6301 Gaston Ave, Suite 400 West Tower Dallas Texas 75214
University of Vermont, Department of Neurology, 89 Beaumont Drive, Given Bldg, Room C-225 Burlington Vermont 05405
University of Virginia, Department of Neurology, 3100 Hospital Drive Charlottesville Virginia 22908

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 15 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00818389, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 18, 2011 · Synced May 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00818389 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →